Protective T cell receptor identification for orthotopic reprogramming of immunity in refractory virus infections
Tanja A. Stief(Ludwig-Maximilians-Universität München), Tobias Feuchtinger(University of Freiburg), Michaela Döring(University Children's Hospital Tübingen), Rupert Handgretinger(STZ eyetrial), Franziska Blaeschke(German Cancer Research Center), Peter Lang(STZ eyetrial), Kevin M. Dennehy(University Hospital Augsburg), Dirk H. Busch(German Center for Infection Research), Thomas Müller(Johns Hopkins University), Lena Jablonowski(University Children's Hospital Tübingen), Semjon Willier(Ludwig-Maximilians-Universität München), Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg), Theresa Kaeuferle(Ludwig-Maximilians-Universität München), Judith Feucht(Memorial Sloan Kettering Cancer Center)
Cited by 2
Related Papers
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
|Journal of Clinical Oncology|2004|2.4k
Human Lymphoid and Myeloid Cell Development in NOD/LtSz- <i>scid IL2R</i> γ <i>null</i> Mice Engrafted with Mobilized Human Hemopoietic Stem Cells,
|The Journal of Immunology|2005|1.7k
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
|Nature Communications|2016|727
Guidelines for the use of flow cytometry and cell sorting in immunological studies <sup>*</sup>
|European Journal of Immunology|2017|554